Use of serum copper and zinc levels in the diagnostic evaluation of endometrioma and epithelial ovarian carcinoma


Korun Z. E. U., ERDEM M., ERDEM A., Onan A., BOZKURT N., ÖKTEM M., ...Daha Fazla

CESKA GYNEKOLOGIE-CZECH GYNAECOLOGY, cilt.88, sa.4, ss.279-286, 2023 (ESCI) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 88 Sayı: 4
  • Basım Tarihi: 2023
  • Doi Numarası: 10.48095/cccg2023279
  • Dergi Adı: CESKA GYNEKOLOGIE-CZECH GYNAECOLOGY
  • Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus, EMBASE
  • Sayfa Sayıları: ss.279-286
  • Gazi Üniversitesi Adresli: Evet

Özet

Objective: The aim of this study is to evaluate serum copper (Cu) and zinc (Zn) levels in patients with epithelial ovarian cancer and endometrioma. Materials and methods: We included 21 epithelial ovarian cancer patients, 47 endometrioma patients, 31 healthy women of reproductive age, and 10 healthy women in menopause. Cu and Zn levels and Cu/ Zn ratios were compared. Results: In the endometrioma group, Cu levels (P = 0.04) and Cu/ Zn ratio (P < 0.01) were higher, while Zn levels (P < 0.01) were lower compared to the control group. The threshold value of 1.15 with 62% sensitivity and 61% specificity was calculated for the Cu/ Zn ratio using the ROC curve (AUC = 0.688; P = 0.005). In the ovarian cancer group, Cu levels (P = 0.01) and Cu/ Zn ratio (P = 0.02) were higher, whereas Zn levels (P = 0.02) were lower compared to the control group. The Cu/ Zn ratio threshold value of 1.37 was calculated with 76% sensitivity and 90% specificity (AUC = 0.829; P = 0.004). The Zn level was lower (P = 0.02), and the Cu/ Zn ratio was higher (P = 0.01) in the ovarian cancer group compared to the endometrioma group. Conclusion: The threshold value of the Cu/ Zn ratio for ovarian cancer could be determined with a specificity of 90%, whereas the sensitivity and specificity of the Cu/ Zn ratio for endometrioma were low.